Standalone Financial Results, Limited Review Report for December 31, 2016
Unichem Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Intimation of Conference Call for Investors & Analysts
Unichem Laboratories Ltd has informed BSE regarding "Intimation of Conference Call for Investors & Analysts". Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Unichem Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Board Meeting Intimation for Results & Closure of Trading Window
Unichem Laboratories Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on January 21, 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.Further, in terms of the Company's Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and... Investor Presentation
Unichem Laboratories Ltd has submitted to BSE a copy of Investor Presentation for Q2 FY 17 Results. Updates
Unichem Laboratories Ltd has submitted to BSE a copy of Transcript on unaudited financial results for the quarter and half year ended September 30, 2016. Unichem Labs net dips 11.3%
Unichem Laboratories today reported a 11.28 per cent dip in standalone net profit at Rs 20.52 crore for the second quarter ended September 30, 2016.The company had posted a net profit of Rs 23.13... Outcome of Board Meeting
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 21, 2016, inter alia, has approved allotment of 4,050 equity shares having a face value of Rs. 2/- each, pursuant to exercise of options under the Employee Stock Option Scheme, 2008.The meeting commenced at 11.30 a.m. and concluded at 12.40 p.m. Investor Release for September 30, 2016
Unichem Laboratories Ltd has informed BSE about Investor Release for the period ended September 30, 2016